Key result
Antihypertensive medication use was associated with increased cardiovascular mortality compared to no treatment in young-old and old-old adults.
Why the study?
Does antihypertensive medication use impact residual cardiovascular mortality risk in elderly individuals aged 60-89 years?
Cohort (n=26,133)
Yes
Does antihypertensive medication use impact residual cardiovascular mortality risk in elderly individuals aged 60-89 years?
Answers are grounded in this paper and cite their sources.
Elderly individuals receiving antihypertensive treatment have a higher residual risk of cardiovascular mortality compared to untreated individuals, indicating a need for continued close monitoring.
OBJECTIVE: There is little evidence to support an increased risk of blood pressure (BP) elevation among elderly individuals receiving antihypertensive drug treatment. METHODS: To clarify the impact on BP level and residual cardiovascular risk in treated elderly individuals, we analysed individual participant data of 26 133 residents aged 60-89 years from seven Japanese general populations and cross-classified participants by age category, 60-74 (young-old) versus 75-89 years (old-old), and by usage of antihypertensive medication at baseline survey (1980-1995). RESULTS: During a median follow-up period of 12.7 years, 2451 cardiovascular deaths were observed. Multivariable-adjusted hazard ratios of cardiovascular mortality in treated participants compared with untreated participants were 1.30 [95% confidence intervals, 1.16-1.46) and 1.35 (95% confidence interval, 1.16-1.56) in young-old and old-old participants, respectively. Irrespective of antihypertensive medication, the risk increase of total cardiovascular and stroke mortality with elevation of BP was significant among young-old (P ≤ 0.0013), but not significant among old-old participants (P ≥ 0.061). CONCLUSION: Although impact on BP was more evident among young-old than old-old individuals, clinicians who prescribe antihypertensive medication to elderly patients should consider that such patients require further monitoring.
No takes yet. Share an insight, caveat, or question.
Asayama et al. (2017) conducted a cohort in Cardiovascular risk (n=26,133). Antihypertensive medication vs. Untreated participants was evaluated on Cardiovascular mortality (HR 1.30, 95% CI 1.16-1.46). Antihypertensive medication use was associated with increased cardiovascular mortality compared to no treatment in young-old and old-old adults.
Synapse has enriched 10 related papers. Consider them for comparative context: